{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:50:00Z","timestamp":1788821400472,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>End-stage renal disease (ESRD) is a rapidly increasing global health and healthcare challenge. MicroRNAs (miRNAs) have been implicated in kidney disease due to their role in apoptosis, cell proliferation, differentiation, and development. The aim of this study was to determine the role of miRNA-21-5p, miRNA-126-3p, and miRNA-192-5p in the prognosis of ESRD. In addition, we aimed to evaluate the discriminatory ability of these miRNAs as biomarkers for ESRD in relation to the comorbidities of hypertension (HTN) and diabetes mellitus (DM). One hundred and ten individuals were recruited for our study and divided into three groups: group 1 included 40 ESRD patients with hypertension, group 2 included 40 ESRD patients with diabetes, and group 3 (<jats:italic>n<\/jats:italic>\u2009=\u200930) served as healthy controls. Real-time polymerase chain reaction (RT-PCR) was used to quantify the above miRNAs. Patients with ESRD were found to have lower levels of miRNA-126-3p and higher levels of miRNAs-21-5p and \u2212\u2009192-5p. Furthermore, the accuracies of ROC analyses for miR-21-5p, miR-126-3p, and miR-192-5p were 96.65%, 99.5%, and 93.35% in ESRD with HTN and 95%, 71.5%, and 93% in ESRD with DM. Dysregulation of these miRNAs is associated with the development of ESRD and could be used as biomarkers for ESRD. This study briefly outlines the challenges associated with miRNA research and the potential use of miRNA molecules in the management of ESRD, proposing a research approach emphasizing the development of standardized and reliable biomarkers for therapeutic use. Despite the promising diagnostic utility demonstrated, the lack of cross-validation and external validation remains an important limitation. Future large-scale, independent studies are essential to confirm these findings and ensure broader applicability.<\/jats:p>","DOI":"10.1038\/s41598-025-16013-5","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T06:34:15Z","timestamp":1756017255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of Micro-RNAs as biomarkers for end-stage renal disease related to hypertension and diabetes"],"prefix":"10.1038","volume":"15","author":[{"given":"Ali","family":"Ata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda S.","family":"Sherkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr E.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Afify","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed D.E.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Azazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5571-142X","authenticated-orcid":false,"given":"Weaam","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"16013_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11255-021-02922-7","volume":"54","author":"B Franczyk","year":"2022","unstructured":"Franczyk, B. et al. MiRNA biomarkers in renal disease. Int. Urol. Nephrol. 54, 575\u2013588 (2022).","journal-title":"Int. Urol. Nephrol."},{"key":"16013_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov, B. et al. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"16013_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/sdi.13164","volume":"37","author":"E Ba\u011fria\u00e7ik","year":"2024","unstructured":"Ba\u011fria\u00e7ik, E. & Dikmen, B. T. Self-management training in patients with chronic kidney disease undergoing hemodialysis: A systematic review. Semin Dial. 37, 91\u2013100 (2024).","journal-title":"Semin Dial"},{"key":"16013_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.ackd.2016.04.005","volume":"23","author":"AD Hazzan","year":"2016","unstructured":"Hazzan, A. D., Halinski, C., Agoritsas, S., Fishbane, S. & DeVita, M. V. Epidemiology and challenges to the management of advanced CKD. Adv. Chronic Kidney Dis. 23, 217\u2013221 (2016).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"16013_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1242\/dmm.027276","volume":"9","author":"LJ Mullins","year":"2016","unstructured":"Mullins, L. J., Conway, B. R., Menzies, R. I., Denby, L. & Mullins, J. J. Renal disease pathophysiology and treatment: contributions from the rat. Dis. Model. Mech. 9, 1419\u20131433 (2016).","journal-title":"Dis. Model. Mech."},{"key":"16013_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow, J. S. et al. Global epidemiology of End-Stage kidney disease and disparities in kidney replacement therapy. Am. J. Nephrol. 52, 98\u2013107 (2021).","journal-title":"Am. J. Nephrol."},{"key":"16013_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/ndt\/gfz183","volume":"36","author":"KL Connor","year":"2021","unstructured":"Connor, K. L. & Denby, L. MicroRNAs as non-invasive biomarkers of renal disease. Nephrol. Dial Transpl. 36, 428\u2013429 (2021).","journal-title":"Nephrol. Dial Transpl."},{"key":"16013_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000478019","volume":"40","author":"H Schwarzenbach","year":"2017","unstructured":"Schwarzenbach, H. Clinical relevance of circulating, Cell-Free and Exosomal MicroRNAs in plasma and serum of breast cancer patients. Oncol. Res. Treat. 40, 423\u2013429 (2017).","journal-title":"Oncol. Res. Treat."},{"key":"16013_CR9","doi-asserted-by":"publisher","unstructured":"Nabawy, M. et al. Impact of some MiRNAs expression on induction of obesity related diseases. Egypt. J. Chem. 0\u20130. https:\/\/doi.org\/10.21608\/ejchem.2024.307399.10085 (2024).","DOI":"10.21608\/ejchem.2024.307399.10085"},{"key":"16013_CR10","doi-asserted-by":"crossref","unstructured":"Gouda, W. et al. Evaluation of the association of some circulating miRNA molecules in the metabolic syndrome. Qatar Med. J. (2024). (2024).","DOI":"10.5339\/qmj.2024.71"},{"key":"16013_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.21608\/epj.2025.407677","volume":"24","author":"M Nabawy","year":"2025","unstructured":"Nabawy, M. et al. Evaluation of some MicroRNAs dysregulation in obesity and obesity-related hypertension. Egypt. Pharm. J. 24, 199\u2013206 (2025).","journal-title":"Egypt. Pharm. J."},{"key":"16013_CR12","doi-asserted-by":"crossref","unstructured":"Sun, Q. et al. The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis. J Cell. Sci 131, (2018).","DOI":"10.1242\/jcs.202317"},{"key":"16013_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1651-0","volume":"20","author":"R Fujii","year":"2019","unstructured":"Fujii, R. et al. Circulating MicroRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the great East Japan earthquake. BMC Nephrol. 20, 1\u20137 (2019).","journal-title":"BMC Nephrol."},{"key":"16013_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.5114\/aoms.2019.87095","volume":"15","author":"L Abdelsalam","year":"2019","unstructured":"Abdelsalam, L. et al. Expression of miRNAs-122, -192 and \u2013\u2009499 in end stage renal disease associated with acute myocardial infarction. Arch. Med. Sci. 15, 1247\u20131253 (2019).","journal-title":"Arch. Med. Sci."},{"key":"16013_CR15","doi-asserted-by":"publisher","first-page":"e64558","DOI":"10.1371\/journal.pone.0064558","volume":"8","author":"NX Chen","year":"2013","unstructured":"Chen, N. X. et al. Decreased MicroRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One. 8, e64558 (2013).","journal-title":"PLoS One"},{"key":"16013_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbadis.2013.10.005","volume":"1842","author":"F Ta\u00efbi","year":"2014","unstructured":"Ta\u00efbi, F. et al. Possible involvement of MicroRNAs in vascular damage in experimental chronic kidney disease. Biochim. Biophys. Acta. 1842, 88\u201398 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"16013_CR17","doi-asserted-by":"publisher","first-page":"e47807","DOI":"10.1371\/journal.pone.0047807","volume":"7","author":"AY Rangrez","year":"2012","unstructured":"Rangrez, A. Y. et al. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLoS One. 7, e47807 (2012).","journal-title":"PLoS One"},{"key":"16013_CR18","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/ijms24021792","volume":"24","author":"D Motshwari","year":"2023","unstructured":"Motshwari, D. et al. MicroRNAs associated with chronic kidney disease in the general population and High-Risk Subgroups\u2014A systematic review. Int. J. Mol. Sci. 24, 1792 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"16013_CR19","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"16013_CR20","unstructured":"Kreutz, R. et al. European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur. J. Intern. Med. 126, 1\u201315 (2024). (2024)."},{"key":"16013_CR21","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024. Diabetes Care. 47, S20\u2013S42 (2024).","journal-title":"Diabetes Care"},{"key":"16013_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"16013_CR23","doi-asserted-by":"publisher","first-page":"28281","DOI":"10.1038\/srep28281","volume":"6","author":"L Yan","year":"2016","unstructured":"Yan, L. et al. MiR-21-5p links Epithelial-Mesenchymal transition phenotype with Stem-Like cell signatures via AKT signaling in keloid keratinocytes. Sci. Rep. 6, 28281 (2016).","journal-title":"Sci. Rep."},{"key":"16013_CR24","doi-asserted-by":"crossref","unstructured":"Kowara, M. et al. MicroRNA inhibiting atheroprotective proteins in patients with unstable angina comparing to chronic coronary syndrome. Int J. Mol. Sci 25, (2024).","DOI":"10.3390\/ijms251910621"},{"key":"16013_CR25","first-page":"4252","volume":"22","author":"F Liu","year":"2018","unstructured":"Liu, F. et al. miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1. Eur. Rev. Med. Pharmacol. Sci. 22, 4252\u20134260 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"16013_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12865-018-0263-y","volume":"19","author":"X Xu","year":"2018","unstructured":"Xu, X. et al. MiR-18a and miR-17 are positively correlated with Circulating PD-1\u2009+\u2009ICOS\u2009+\u2009follicular helper T cells after hepatitis B vaccination in a Chinese population. BMC Immunol. 19, 25 (2018).","journal-title":"BMC Immunol."},{"key":"16013_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra, P. et al. Descriptive statistics and normality tests for statistical data. Ann. Card Anaesth. 22, 67\u201372 (2019).","journal-title":"Ann. Card Anaesth."},{"key":"16013_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ YOUDEN","year":"1950","unstructured":"YOUDEN, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335 (1950).","journal-title":"Cancer"},{"key":"16013_CR29","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. A review of long non-coding RNAs in ankylosing spondylitis: pathogenesis, clinical assessment, and therapeutic targets. Front Cell. Dev. Biol 12, (2024).","DOI":"10.3389\/fcell.2024.1362476"},{"key":"16013_CR30","doi-asserted-by":"crossref","unstructured":"Al-Dmour, B. A., Al-Nawayseh, A. H. T., Al-Tarawneh, M. A. & Hani, Z. M. B. Antecedents of mental disorder among physically inactive employees study of Jordanian higher education institutions: mediated moderation of perceived threat of Covid-19 and psychological capital. Pakistan J. Life Soc. Sci 21, (2023).","DOI":"10.57239\/PJLSS-2023-21.1.001"},{"key":"16013_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1574893614666190923115032","volume":"15","author":"A Khan","year":"2020","unstructured":"Khan, A., Zahra, A., Mumtaz, S., Fatmi, M. Q. & Khan, M. J. Integrated In-silico analysis to study the role of MicroRNAs in the detection of chronic kidney diseases. Curr. Bioinform. 15, 144\u2013154 (2020).","journal-title":"Curr. Bioinform"},{"key":"16013_CR32","first-page":"5905","volume":"22","author":"RA Ibrahim","year":"2024","unstructured":"Ibrahim, R. A. & Saadoon, I. H. The role of miRNA- 126 in the development of end stage renal disease. Pakistan J. Life Soc. Sci. 22, 5905\u20135913 (2024).","journal-title":"Pakistan J. Life Soc. Sci."},{"key":"16013_CR33","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.3390\/ijms221910549","volume":"22","author":"O Fourdinier","year":"2021","unstructured":"Fourdinier, O. et al. Syndecan-1 and free indoxyl sulfate levels are associated with miR-126 in chronic kidney disease. Int. J. Mol. Sci. 22, 10549 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"16013_CR34","doi-asserted-by":"publisher","first-page":"101937","DOI":"10.1016\/j.isci.2020.101937","volume":"24","author":"KM Scullion","year":"2021","unstructured":"Scullion, K. M. et al. Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease. iScience 24, 101937 (2021).","journal-title":"iScience"},{"key":"16013_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cca.2021.07.002","volume":"521","author":"R Fujii","year":"2021","unstructured":"Fujii, R. et al. Association between Circulating MicroRNAs and changes in kidney function: A five-year prospective study among Japanese adults without CKD. Clin. Chim. Acta. 521, 97\u2013103 (2021).","journal-title":"Clin. Chim. Acta"},{"key":"16013_CR36","doi-asserted-by":"crossref","unstructured":"Carmona, A. et al. Inflammation, senescence and MicroRNAs in chronic kidney disease. Front Cell. Dev. Biol 8, (2020).","DOI":"10.3389\/fcell.2020.00739"},{"key":"16013_CR37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1139\/cjpp-2020-0581","volume":"99","author":"DND Nguyen","year":"2021","unstructured":"Nguyen, D. N. D., Chilian, W. M., Zain, S. M., Daud, M. F. & Pung, Y. F. MicroRNA regulation of vascular smooth muscle cells and its significance in cardiovascular diseases. Can. J. Physiol. Pharmacol. 99, 827\u2013838 (2021).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"16013_CR38","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.2174\/1381612826666200504120737","volume":"26","author":"P Nammian","year":"2020","unstructured":"Nammian, P., Razban, V., Tabei, S. M. B. & Asadi-Yousefabad, S. L. MicroRNA-126: dual role in angiogenesis dependent diseases. Curr. Pharm. Des. 26, 4883\u20134893 (2020).","journal-title":"Curr. Pharm. Des."},{"key":"16013_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11255-021-02928-1","volume":"54","author":"R Donderski","year":"2022","unstructured":"Donderski, R. et al. Analysis of profibrogenic MicroRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1\u20134 patients and their relationship with proteinuria and kidney function. Int. Urol. Nephrol. 54, 937\u2013947 (2022).","journal-title":"Int. Urol. Nephrol."},{"key":"16013_CR40","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1111\/jcmm.14317","volume":"23","author":"T Lange","year":"2019","unstructured":"Lange, T. et al. MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury. J. Cell. Mol. Med. 23, 4839\u20134843 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"16013_CR41","doi-asserted-by":"publisher","first-page":"10900","DOI":"10.1038\/s41598-019-47504-x","volume":"9","author":"J Zang","year":"2019","unstructured":"Zang, J., Maxwell, A. P., Simpson, D. A. & McKay, G. J. Differential expression of urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in individuals with diabetic kidney disease. Sci. Rep. 9, 10900 (2019).","journal-title":"Sci. Rep."},{"key":"16013_CR42","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/13813455.2021.1922457","volume":"129","author":"M Khokhar","year":"2023","unstructured":"Khokhar, M. et al. Metformin mediates MicroRNA-21 regulated Circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study. Arch. Physiol. Biochem. 129, 1200\u20131210 (2023).","journal-title":"Arch. Physiol. Biochem."},{"key":"16013_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/ijn.IJN_80_19","volume":"30","author":"M Fouad","year":"2020","unstructured":"Fouad, M., Salem, I., Elhefnawy, K., Raafat, N. & Faisal, A. MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes. Indian J. Nephrol. 30, 21\u201325 (2020).","journal-title":"Indian J. Nephrol."},{"key":"16013_CR44","doi-asserted-by":"crossref","unstructured":"Sayilar, E. I. Biomarker potential of urine miR-451 at different stages of diabetic nephropathy. J Diabetes Metab 07, (2016).","DOI":"10.4172\/2155-6156.1000650"},{"key":"16013_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/JCI75852","volume":"125","author":"IG Gomez","year":"2015","unstructured":"Gomez, I. G. et al. Anti\u2013microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J. Clin. Invest. 125, 141\u2013156 (2015).","journal-title":"J. Clin. Invest."},{"key":"16013_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbadis.2016.10.027","volume":"1863","author":"V Metzinger-Le Meuth","year":"2017","unstructured":"Metzinger-Le Meuth, V., Burtey, S., Maitrias, P., Massy, Z. A. & Metzinger, L. MicroRNAs in the pathophysiology of CKD-MBD: biomarkers and innovative drugs. Biochim. Biophys. Acta - Mol. Basis Dis. 1863, 337\u2013345 (2017).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"16013_CR47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00125-012-2804-x","volume":"56","author":"X Zhong","year":"2013","unstructured":"Zhong, X. et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56, 663\u2013674 (2013).","journal-title":"Diabetologia"},{"key":"16013_CR48","doi-asserted-by":"publisher","first-page":"F931","DOI":"10.1152\/ajprenal.00523.2015","volume":"310","author":"IG Gomez","year":"2016","unstructured":"Gomez, I. G., Nakagawa, N. & Duffield, J. S. MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis. Am. J. Physiol. Ren. Physiol. 310, F931\u2013F944 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"16013_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41544-019-0042-9","volume":"2","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. & Yang, J. Implications of MicroRNA in kidney metabolic disorders. ExRNA 2, 4 (2020).","journal-title":"ExRNA"},{"key":"16013_CR50","doi-asserted-by":"crossref","unstructured":"Chau, B. N. et al. MicroRNA-21 promotes fibrosis of the kidney by Silencing metabolic pathways. Sci Transl Med 4, (2012).","DOI":"10.1126\/scitranslmed.3003205"},{"key":"16013_CR51","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00125-014-3282-0","volume":"57","author":"F He","year":"2014","unstructured":"He, F. et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 57, 1726\u20131736 (2014).","journal-title":"Diabetologia"},{"key":"16013_CR52","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2217\/bmm-2019-0124","volume":"13","author":"L Petrica","year":"2019","unstructured":"Petrica, L. et al. Interleukins and MiRNAs intervene in the early stages of diabetic kidney disease in type 2 diabetes mellitus patients. Biomark. Med. 13, 1577\u20131588 (2019).","journal-title":"Biomark. Med."},{"key":"16013_CR53","doi-asserted-by":"crossref","unstructured":"Jia, Y. et al. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy. J. Diabetes Res. 7932765 (2016). (2016).","DOI":"10.1155\/2016\/7932765"},{"key":"16013_CR54","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1042\/BST20120085","volume":"40","author":"RH Jenkins","year":"2012","unstructured":"Jenkins, R. H., Martin, J., Phillips, A. O., Bowen, T. & Fraser, D. J. Pleiotropy of microRNA-192 in the kidney. Biochem. Soc. Trans. 40, 762\u2013767 (2012).","journal-title":"Biochem. Soc. Trans."},{"key":"16013_CR55","doi-asserted-by":"crossref","unstructured":"Ma, X., Lu, C., Lv, C., Wu, C. & Wang, Q. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio. J. Diabetes Res. 6789402 (2016). (2016).","DOI":"10.1155\/2016\/6789402"},{"key":"16013_CR56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jim-2017-000556","volume":"66","author":"O Milas","year":"2018","unstructured":"Milas, O. et al. Deregulated profiles of urinary MicroRNAs May explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus. J. Investig Med. 66, 747\u2013754 (2018).","journal-title":"J. Investig Med."},{"key":"16013_CR57","first-page":"1171","volume":"18","author":"G Al-Kafaji","year":"2018","unstructured":"Al-Kafaji, G. & Al-Muhtaresh, H. A. Expression of microRNA\u2013377 and microRNA\u2013192 and their potential as blood\u2013based biomarkers for early detection of type 2 diabetic nephropathy. Mol. Med. Rep. 18, 1171\u20131180 (2018).","journal-title":"Mol. Med. Rep."},{"key":"16013_CR58","doi-asserted-by":"publisher","first-page":"118420","DOI":"10.1016\/j.ecoenv.2025.118420","volume":"300","author":"W Chaiwangyen","year":"2025","unstructured":"Chaiwangyen, W., Khantamat, O., Kangwan, N., Tipsuwan, W. & de Sousa, F. L. P. MicroRNA expression in response to environmental hazards: implications for health. Ecotoxicol. Environ. Saf. 300, 118420 (2025).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"16013_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12920-025-02091-x","volume":"18","author":"L Kamkar","year":"2025","unstructured":"Kamkar, L., Saberi, S., Totonchi, M. & Kavousi, K. Circulating MicroRNA panels for multi-cancer detection and gastric cancer screening: leveraging a network biology approach. BMC Med. Genomics. 18, 27 (2025).","journal-title":"BMC Med. Genomics"},{"key":"16013_CR60","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1080\/14796694.2025.2514930","volume":"21","author":"W Wang","year":"2025","unstructured":"Wang, W. et al. Testing the accuracy of a three-miRNA panel for the detection of primary prostate cancer: a discovery and validation study. Future Oncol. 21, 2167\u20132176 (2025).","journal-title":"Future Oncol."},{"key":"16013_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12882-024-03702-y","volume":"25","author":"G Garmaa","year":"2024","unstructured":"Garmaa, G. et al. Panel MiRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis. BMC Nephrol. 25, 261 (2024).","journal-title":"BMC Nephrol."},{"key":"16013_CR62","doi-asserted-by":"crossref","unstructured":"Matshazi, D. M. et al. Circulating levels of MicroRNAs associated with hypertension: A Cross-Sectional study in male and female South African participants. Front Genet 12, (2021).","DOI":"10.3389\/fgene.2021.710438"},{"key":"16013_CR63","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.3390\/ijms25126430","volume":"25","author":"B Kondracki","year":"2024","unstructured":"Kondracki, B. et al. MicroRNA expression in patients with coronary artery disease and Hypertension\u2014A systematic review. Int. J. Mol. Sci. 25, 6430 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"16013_CR64","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","volume":"107","author":"S Fichtlscherer","year":"2010","unstructured":"Fichtlscherer, S. et al. Circulating MicroRNAs in patients with coronary artery disease. Circ. Res. 107, 677\u2013684 (2010).","journal-title":"Circ. Res."},{"key":"16013_CR65","doi-asserted-by":"publisher","first-page":"H1085","DOI":"10.1152\/ajpheart.00191.2012","volume":"303","author":"AJ Tijsen","year":"2012","unstructured":"Tijsen, A. J., Pinto, Y. M. & Creemers, E. E. Circulating MicroRNAs as diagnostic biomarkers for cardiovascular diseases. Am. J. Physiol. Heart Circ. Physiol. 303, H1085\u2013H1095 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"16013_CR66","doi-asserted-by":"publisher","first-page":"117953","DOI":"10.1016\/j.biopha.2025.117953","volume":"185","author":"B Guo","year":"2025","unstructured":"Guo, B. et al. MicroRNA-126: from biology to therapeutics. Biomed. Pharmacother. 185, 117953 (2025).","journal-title":"Biomed. Pharmacother"},{"key":"16013_CR67","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.omtn.2023.02.012","volume":"31","author":"MN Le","year":"2023","unstructured":"Le, M. N. & Nguyen, T. A. Innovative MicroRNA quantification by qPCR. Mol. Ther. Nucleic Acids. 31, 628\u2013630 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"16013_CR68","doi-asserted-by":"crossref","unstructured":"Wang, Z. Y. et al. Advances in Point-of-Care Testing of microRNAs Based on Portable Instruments and Visual Detection. Biosensors 13, (2023).","DOI":"10.3390\/bios13070747"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16013-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16013-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16013-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:02:13Z","timestamp":1757426533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16013-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16013"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16013-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Medical Research Ethics Committee of the National Research Centre, Egypt (approval number: 13060121-3) and was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"31101"}}